Akeso Inc. (4RY)
FSX
Closed
Aug 24, 2026
Day's Range
9.5952 wk Range
9.16Overview - 4RY - Akeso Inc.
Key Statistics
Valuation
Enterprise Value
552.82M
P/E (Trailing)
‪25.32‬
Price / Sales (TTM)
‪2.96‬
Price / Book
‪7.86‬
EV / EBITDA
‪-5.76‬
Profitability
Profit Margin
‪-36.41%‬
Operating Margin
‪-30.66%‬
Return on Assets
‪-4.32%‬
Return on Equity
‪-14.53%‬
Ownership
Shares Outstanding
921.14M
Float
721.54M
Held by Insiders
‪21.66%‬
Held by Institutions
‪32.51%‬
Price stats
Beta
‪0.02‬
50-Day Avg
‪10.43‬
200-Day Avg
‪12.17‬
Dividends
Payout Ratio
‪0.00%‬
Market Cap - 4RY - Akeso Inc.
Peers - 4RY - Akeso Inc.
Peer Comparison
Compared with companies in Biotechnology listed on FSX.
- 4RYFSXAkeso Inc.9.06BMarket Cap-92.15%52-week change25.32P/E (Trailing)‪-36.41%‬Profit Margin
- ANLFSXAnalog Devices, Inc.155.74BMarket Cap+33.03%52-week change44.47P/E (Trailing)‪29.78%‬Profit Margin
- 1AEFSXargenx SE54.66BMarket Cap+32.95%52-week change39.15P/E (Trailing)‪32.26%‬Profit Margin
- 1AEAFSXargenx SE American Depositary Receipt54.41BMarket Cap+34.86%52-week change38.91P/E (Trailing)‪32.26%‬Profit Margin
- 0QFFSXModerna, Inc.50.02BMarket Cap+82.32%52-week change25.27P/E (Trailing)‪-141.42%‬Profit Margin
- 42ZFSXRevolution Medicines Inc.38.84BMarket Cap+82.79%52-week change-30.46P/E (Trailing)‪0.00%‬Profit Margin
- 49BAFSXBeOne Medicines, Ltd. American Depositary Receipt35.97BMarket Cap+14.46%52-week change66.67P/E (Trailing)‪10.69%‬Profit Margin
Profile Summary - 4RY - Akeso Inc.
About
Akeso Inc. is a biopharmaceutical company focused on the research, development, and commercialization of innovative, therapeutic solutions for the treatment of various diseases, particularly relating to oncology and autoimmune disorders. As a key player in the pharmaceutical industry, Akeso Inc. specializes in…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
